West Pharmaceutical Services Stock Statistic Functions Linear Regression Slope

WST Stock

USD 240.33 4.87 2.07%

The statistic functions view organizes Linear Regression Slope function and supporting indicators around West Pharmaceutical. The analysis highlights statistical functions describing dispersion and variability and frames technical signals with volatility and risk context.Provide Time Period to run this model.

Symbol

This analysis covers thirty-eight data points across the selected time horizon. The Linear Regression Slope is the rate of change in West Pharmaceutical price series over its benchmark or peer price series.

West Pharmaceutical Technical Analysis Modules

Most technical analysis of West Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for West from various momentum indicators to cycle indicators. When you analyze West charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10065 people. Liquidity and trading activity can influence how quickly new information is reflected in West Pharmaceutical's price. Lower trading activity may introduce occasional variability in execution conditions. West Pharmaceutical has a market cap of 16.96 B, P/E of 40.71, ROE of 16.86%.

Methodology

Unless otherwise specified, financial data for West Pharmaceutical Services is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. West (USA Stocks:WST) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for West Pharmaceutical Services is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

West Pharmaceutical Services has active sell-side coverage. Source-validated coverage currently shows 16 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 8 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Goldman Sachs, Jefferies, Bank of America Securities, Morgan Stanley, Barclays, Evercore ISI, Deutsche Bank, Wells Fargo Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor

Last reviewed on February 28th, 2026

Learn to be your own money manager

A reliable portfolio-monitoring process is important because investors need to see whether West Pharmaceutical Services is improving total return without quietly increasing concentration or risk. The stronger process keeps portfolio transparency high without forcing constant manual review of every holding.

Did you try this?

Run Portfolio Center Now

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios

All Next

Launch Module

West Pharmaceutical pair trading

Using West Pharmaceutical in a pair-trading setup can improve risk control because gains and losses are judged against a second position instead of against the market alone. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

West Pharmaceutical Pair Trading

West Pharmaceutical Services Pair Trading Analysis

Pair-trading logic also applies to tax-loss harvesting: by identifying an asset with near-identical factor exposures to West Pharmaceutical Services, investors can effectively maintain a synthetic West Pharmaceutical position while the wash-sale clock resets.

The correlation structure around West Pharmaceutical evolves as market regimes change. Assets that were once uncorrelated with West Pharmaceutical may become correlated during crises, so investors should monitor rolling correlations alongside static long-run averages.

Pair evaluation and Correlation analysis for West Pharmaceutical provide hedging context. The method can be applied across sectors and broader equity sets.

Pair Correlation Correlation Matching

Additional Tools for West Stock Analysis

	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Commodity Directory Find actively traded commodities issued by global exchanges
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	CEOs Directory Screen CEOs from public companies around the world
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC